Lady Paula Dejesus, DPM
Foot & Ankle Surgery · Brooklyn, NYNPI 1558643221
Payments from drug & device makers
Across 73 payments — averaging $231.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osteomed LLC$7K
- Gotham Surgical Solutions & Devices, Inc.$2K
- Arthrex$2K
- Team 1, LLC$2K
- Biotissue Holdings Inc.$716
- Stryker$454
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$7,00041%
- Travel & lodging$2,95117%
- Food & beverage$2,10212%
- Education$4,83029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osteomed LLC | 16 | $7,272 |
| Gotham Surgical Solutions & Devices, Inc. | 4 | $2,456 |
| Arthrex | 3 | $2,347 |
| Team 1, LLC | 1 | $1,849 |
| Biotissue Holdings Inc. | 3 | $716 |
| Stryker | 8 | $454 |
| Acumed LLC | 5 | $354 |
| Polynovo North America LLC | 6 | $216 |
| Kerecis Limited | 1 | $172 |
| Advanced Oxygen Therapy Inc. | 2 | $165 |
| Integra Lifesciences Corporation | 5 | $163 |
| Medartis Inc. | 2 | $161 |
| Ossio Inc | 1 | $110 |
| Organogenesis Inc. | 2 | $66 |
| Medtronic | 1 | $60 |
| Smith+Nephew | 1 | $50 |
| Paratek Pharmaceuticals, Inc. | 2 | $46 |
| Zimvie Inc. | 1 | $42 |
| AbbVie | 2 | $36 |
| Bioventus LLC | 2 | $34 |
| Kuros Biosciences USA, Inc | 1 | $29 |
| GRT US Holding, Inc. | 1 | $27 |
| Solventum Corporation | 1 | $23 |
| Abbott | 1 | $23 |
| Lifenet Health | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Other$4,500
- EXT-Extremilock Foot$4,500
- EXT-ExtremiLock Ankle$4,500
- EXT-ExtremiFix Midsize/Large$4,500
- EXT-Hemi$3,500
- EXT-Encompass$2,500
- EXT-Cannulated$1,000
- Prokera$686
- AmnioGraft$686
- AmnioGuard$686
- Kerecis Omega3 Marigen$517
- Kerecis Omega3 SurgiClose$172
- Kerecis Omega3 GraftGuide$172
- PROstep$171
- APTUS$136
How this compares
$16,883 in reported general payments places this provider in the 85th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 152 | $3,333 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 38 | $1,730 |
| Diclofenac Sodium | 33 | $685 |
| Ammonium Lactate | 31 | $675 |
| Gentamicin Sulfate | 19 | $652 |
| Nystatin | 30 | $478 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $299 |
| Doxycycline Hyclate | 29 | $294 |
| Clotrimazole | 17 | $246 |
| Cefadroxil | 11 | $139 |
| Triamcinolone Acetonide | 17 | $128 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $68 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Brooklyn
- Edward AzarBrooklyn$224K
- William SpielfogelBrooklyn$111K
- David MandilBrooklyn$56K
- Yury RotshteynBrooklyn$43K
- Mario VoloshinBrooklyn$33K
- Bryan MakowerBrooklyn$28K
- Amit GandhiBrooklyn$21K
- James McWilliamHarrison$4.7M
- Jonathan DelandNew York$4.1M
- George Vitole Roy$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.